背景:常规疫苗接种程序,虽然对公共卫生至关重要,会引起疼痛,恐惧,和儿童的焦虑。已经提出了诸如虚拟现实和万花筒之类的分心技术来减轻疫苗接种期间的这些负面经历。
目的:本研究旨在比较虚拟现实和万花筒作为减轻疼痛的分散方法的有效性,恐惧,48个月儿童常规疫苗接种期间的焦虑。
方法:这项随机对照试验将接受麻疹-腮腺炎-风疹疫苗的48个月大的儿童分为三组:虚拟现实(n=42),万花筒(n=42),和对照(n=42)。
方法:本研究在儿科诊所进行。
方法:本研究共纳入126名48个月大的儿童。
方法:研究人员和儿童在接种疫苗前后评估疼痛和恐惧水平。而儿童在接种疫苗后评估焦虑。使用WongBaker面部疼痛评定量表测量疼痛,恐惧与儿童的恐惧量表,和焦虑与儿童焦虑量表状态版本。
结果:疫苗接种后疼痛,恐惧,与虚拟现实组和对照组相比,万花筒组的焦虑评分明显较低(p<0.05)。
结论:在48个月大的儿童接种疫苗期间使用万花筒可有效减轻疼痛,恐惧,和焦虑。在常规疫苗接种程序中整合万花筒作为分散注意力的方法可以增强疫苗接种体验并可能改善对疫苗接种时间表的依从性。
背景:临床试验编号为NCT0611XXXX。
BACKGROUND: Routine vaccination procedures, while crucial for public health, can induce pain, fear, and anxiety in children.
Distraction techniques such as virtual reality and kaleidoscope have been proposed to alleviate these negative experiences during vaccinations.
OBJECTIVE: This study aimed to compare the effectiveness of virtual reality and kaleidoscope as
distraction methods in reducing pain, fear, and anxiety during routine vaccination in children aged 48 months.
METHODS: This randomized controlled trial allocated children aged 48 months receiving the measles-mumps-rubella vaccine into three groups: virtual reality (n = 42), kaleidoscope (n = 42), and control (n = 42).
METHODS: The study was conducted in a pediatric clinic.
METHODS: The study included a total of 126 children aged 48 months.
METHODS: Pain and fear levels were assessed by both researchers and children before and after the vaccination procedure, while anxiety was evaluated by children after vaccination. Pain was measured using the Wong Baker Faces Pain Rating Scale, fear with the Children\'s Fear Scale, and anxiety with the Child Anxiety Scale-State Version.
RESULTS: Post-vaccination pain, fear, and anxiety scores were significantly lower in the kaleidoscope group compared to both the virtual reality and control groups (p < .05).
CONCLUSIONS: Using kaleidoscope during vaccination in 48-month-old children effectively reduced pain, fear, and anxiety. Integrating kaleidoscope as a
distraction method during routine vaccination procedures may enhance the vaccination experience and potentially improve adherence to vaccination schedules.
BACKGROUND: Clinical trials number is NCT0611XXXX.